tiprankstipranks
Aptevo, Alligator Bioscience report interim data of ALG.APV-527 Phase 1 trial
PremiumThe FlyAptevo, Alligator Bioscience report interim data of ALG.APV-527 Phase 1 trial
2M ago
Aptevo price target adjusted to $10.50 from $4.75 at Alliance Global Partners
PremiumThe Fly
Aptevo price target adjusted to $10.50 from $4.75 at Alliance Global Partners
2M ago
Aptevo Therapeutics trading halted, news pending
PremiumThe Fly
Aptevo Therapeutics trading halted, news pending
2M ago
Aptevo Therapeutics initiated with a Buy at Alliance Global Partners
PremiumThe FlyAptevo Therapeutics initiated with a Buy at Alliance Global Partners
7M ago
Aptevo Therapeutics price target lowered to $12 from $18 at Roth MKM
PremiumThe Fly
Aptevo Therapeutics price target lowered to $12 from $18 at Roth MKM
9M ago
Aptevo Therapeutics reports Q2 EPS ($1.23) vs. $5.55 last year
PremiumThe Fly
Aptevo Therapeutics reports Q2 EPS ($1.23) vs. $5.55 last year
9M ago
APVO Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsAPVO Upcoming Earnings Report: What to Expect?
12M ago
Aptevo Therapeutics reports 2022 EPS $1.57 vs. ($6.07) last year
PremiumThe Fly
Aptevo Therapeutics reports 2022 EPS $1.57 vs. ($6.07) last year
1y ago
Aptevo Therapeutics raises $9.6M in non-dilutive funding
PremiumThe Fly
Aptevo Therapeutics raises $9.6M in non-dilutive funding
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100